Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Dianthus Therapeutics
DNTH
$5.84B
| $415K | ﹤0.01% |
2,194
-224
| -9% | -$37.7K |
|
|
NEWR
3252
DELISTED
New Relic, Inc.
NEWR
| $415K | ﹤0.01% |
6,743
-1,580
| -19% | -$105K |
|
3253
Organogenesis Holdings
ORGO
$305M
| $413K | ﹤0.01% |
22,645
+9,503
| +72% | +$129K |
|
3254
Nordic American Tanker
NAT
$1.38B
| $412K | ﹤0.01% |
126,725
-26,453
| -17% | -$85.3K |
|
3255
Precision BioSciences
DTIL
$180M
| $411K | ﹤0.01% |
1,322
+512
| +63% | +$179K |
|
3256
PUT
General Mills
GIS
$19.1B
| $411K | ﹤0.01% |
6,700
-18,800
| -74% | -$1.08M |
|
3257
NexGen Energy
NXE
$6.06B
| $411K | ﹤0.01% |
113,200
+100,000
| +758% | +$340K |
|
3258
Radiant Logistics
RLGT
$386M
| $411K | ﹤0.01% |
59,159
+20,078
| +51% | +$133K |
|
3259
TherapeuticsMD
TXMD
$23.5M
| $411K | ﹤0.01% |
6,134
+4,441
| +262% | +$348K |
|
3260
Foster
FSTR
$430M
| $410K | ﹤0.01% |
22,860
+8,732
| +62% | +$146K |
|
3261
Sprott Physical Silver Trust
PSLV
$12B
| $410K | ﹤0.01% |
46,656
| – | – |
|
3262
PUT
ProShares Ultra S&P500
SSO
$7.87B
| $409K | ﹤0.01% |
16,000
-46,400
| -74% | -$1.12M |
|
3263
Brown-Forman Class A
BF.A
$13.4B
| $408K | ﹤0.01% |
6,414
-2,836
| -31% | -$193K |
|
3264
Hudbay
HBM
$10.1B
| $408K | ﹤0.01% |
+59,360
| New | +$408K |
|
3265
ProShares UltraPro S&P 500
UPRO
$5.23B
| $408K | ﹤0.01% |
9,048
+3,006
| +50% | +$126K |
|
|
LEVL
3266
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $408K | ﹤0.01% |
15,808
+5,594
| +55% | +$125K |
|
|
FLIC
3267
DELISTED
First of Long Island Corp
FLIC
| $406K | ﹤0.01% |
19,096
+11,743
| +160% | +$223K |
|
3268
Telephone and Data Systems
TDS
$3.82B
| $405K | ﹤0.01% |
17,620
+1,516
| +9% | +$31K |
|
3269
Funko
FNKO
$326M
| $404K | ﹤0.01% |
20,511
+12,616
| +160% | +$176K |
|
|
ORAN
3270
DELISTED
Orange
ORAN
| $404K | ﹤0.01% |
32,751
+15,759
| +93% | +$190K |
|
3271
KALA BIO
KALA
$14.1M
| $403K | ﹤0.01% |
24
+19
| +380% | +$371K |
|
3272
Financial Institutions
FISI
$816M
| $402K | ﹤0.01% |
13,242
+8,130
| +159% | +$220K |
|
3273
Pampa Energía
PAM
$4.75B
| $402K | ﹤0.01% |
27,100
-10,300
| -28% | -$141K |
|
3274
MediciNova
MNOV
$65.5M
| $401K | ﹤0.01% |
79,331
+44,469
| +128% | +$259K |
|
|
EHT
3275
DELISTED
Eaton Vance 2021 Target Term Trust
EHT
| $401K | ﹤0.01% |
+40,560
| New | +$398K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.